{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:26Z","timestamp":1792590146499,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06356-w","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:15:39Z","timestamp":1784956539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the remnant cholesterol inflammatory index and frailty with cardiometabolic multimorbidity among Chinese middle-aged and elderly populations: a nationwide cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Shiyuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"1","key":"6356_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"3","key":"6356_CR2","doi-asserted-by":"publisher","first-page":"e024476","DOI":"10.1136\/bmjopen-2018-024476","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476.","journal-title":"BMJ Open"},{"issue":"6","key":"6356_CR3","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s11357-023-00852-z","volume":"45","author":"E Hickman","year":"2023","unstructured":"Hickman E, Seawoodharry M, Gillies C, Khunti K, Seidu S. Deprescribing in cardiometabolic conditions in older patients: a systematic review. GeroScience. 2023;45(6):3491\u2013512.","journal-title":"GeroScience"},{"issue":"1","key":"6356_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/ageing\/afaa117","volume":"50","author":"YW Zhao","year":"2021","unstructured":"Zhao YW, Haregu TN, He L, Lu S, Katar A, Wang H, et al. The effect of multimorbidity on functional limitations and depression amongst middle-aged and older population in China: a nationwide longitudinal study. Age Ageing. 2021;50(1):190\u20137.","journal-title":"Age Ageing"},{"key":"6356_CR5","doi-asserted-by":"publisher","first-page":"913869","DOI":"10.3389\/fcvm.2022.913869","volume":"9","author":"K Wang","year":"2022","unstructured":"Wang K, Wang R, Yang J, Liu X, Shen H, Sun Y, et al. Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment. Front Cardiovasc Med. 2022;9:913869.","journal-title":"Front Cardiovasc Med"},{"key":"6356_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","volume":"76","author":"J Chen","year":"2025","unstructured":"Chen J, Wu Q, Liu H, Hu W, Zhu J, Ji Z, et al. Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China health and retirement longitudinal study. J Adv Res. 2025;76:543\u201352.","journal-title":"J Adv Res"},{"key":"6356_CR7","doi-asserted-by":"publisher","first-page":"11291","DOI":"10.2147\/JIR.S477860","volume":"17","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen Q, Chen Q, Hou J, Li X, Fu J, et al. A synergistic effect of remnant cholesterol and C-reactive protein on predicting the severity of coronary artery disease. J Inflamm Res. 2024;17:11291\u2013303.","journal-title":"J Inflamm Res"},{"issue":"3","key":"6356_CR8","first-page":"916","volume":"4","author":"M Pansuria","year":"2012","unstructured":"Pansuria M, Xi H, Li L, Yang XF, Wang H. Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci (Schol Ed). 2012;4(3):916\u201331.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"10","key":"6356_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.31083\/j.rcm2410297","volume":"24","author":"K Kirkgoz","year":"2023","unstructured":"Kirkgoz K. C-reactive protein in atherosclerosis-more than a biomarker, but not just a culprit. Rev Cardiovasc Med. 2023;24(10):297.","journal-title":"Rev Cardiovasc Med"},{"issue":"9","key":"6356_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/bjo-2023-325044","volume":"109","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang X, Liang A, Niu Y, Chen D, Du Z, et al. High-sensitivity C-reactive protein and risk of retinal artery occlusion and ischaemic stroke: a cross-cohort study. Br J Ophthalmol. 2025;109(9):1081\u20137.","journal-title":"Br J Ophthalmol"},{"key":"6356_CR11","doi-asserted-by":"publisher","first-page":"1618157","DOI":"10.3389\/fendo.2025.1618157","volume":"16","author":"PA Lian","year":"2025","unstructured":"Lian PA, Xie F, Zhang W, Cheng S, Zhao YF, Li L, et al. Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a national cohort of middle-aged and older Chinese adults. Front Endocrinol (Lausanne). 2025;16:1618157.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6356_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-020-00472-w","volume":"17","author":"R Xu","year":"2020","unstructured":"Xu R, Jiang X, Fan Z, Wan Y, Gao X. The trajectory of high sensitivity C-reactive protein is associated with incident diabetes in Chinese adults. Nutr Metab (Lond). 2020;17:49.","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"6356_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12944-025-02850-w","volume":"25","author":"W Zhang","year":"2026","unstructured":"Zhang W, Jing C, Liu X, Hou H. Cumulative average remnant cholesterol inflammatory index and risk of cardiometabolic multimorbidity: evidence from a prospective nationwide cohort study in China. Lipids Health Dis. 2026;25(1):41.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"6356_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1159\/000528561","volume":"69","author":"P Doody","year":"2023","unstructured":"Doody P, Lord JM, Greig CA, Whittaker AC. Frailty: pathophysiology, theoretical and operational definition(s), impact, prevalence, management and prevention, in an increasingly economically developed and ageing world. Gerontology. 2023;69(8):927\u201345.","journal-title":"Gerontology"},{"issue":"4","key":"6356_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11357-017-9993-7","volume":"39","author":"JM Blodgett","year":"2017","unstructured":"Blodgett JM, Theou O, Howlett SE, Rockwood K. A frailty index from common clinical and laboratory tests predicts increased risk of death across the life course. GeroScience. 2017;39(4):447\u201355.","journal-title":"GeroScience"},{"issue":"5","key":"6356_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173(5):489\u201395.","journal-title":"Can Med Assoc J"},{"issue":"1","key":"6356_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41514-025-00301-5","volume":"12","author":"RH Zhang","year":"2025","unstructured":"Zhang RH, Wang J, Wang Y, Li RQ, Lu TY, Zhou BJ, et al. Frailty and transitions across cardiometabolic disease states: evidence from multistate models in a 16-year Chinese cohort. NPJ Aging. 2025;12(1):4.","journal-title":"NPJ Aging"},{"issue":"5","key":"6356_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jacc.2021.11.029","volume":"79","author":"N Ijaz","year":"2022","unstructured":"Ijaz N, Buta B, Xue QL, Mohess DT, Bushan A, Tran H, et al. Interventions for frailty among older adults with cardiovascular disease: JACC State-of-the-art review. J Am Coll Cardiol. 2022;79(5):482\u2013503.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"6356_CR19","doi-asserted-by":"publisher","first-page":"e0309837","DOI":"10.1371\/journal.pone.0309837","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang L, Li X, Luo A, Guo S, Liu X, et al. Prevalence and risk factors of frailty in older adults with diabetes: a systematic review and meta-analysis. PLoS ONE. 2024;19(10):e0309837.","journal-title":"PLoS ONE"},{"key":"6356_CR20","doi-asserted-by":"crossref","unstructured":"Burton JK, Stewart J, Blair M, Oxley S, Wass A, Taylor-Rowan M, et al. Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis. Age Ageing. 2022;51(3):afac064.","DOI":"10.1093\/ageing\/afac064"},{"key":"6356_CR21","doi-asserted-by":"crossref","unstructured":"Fan H, Jiang G, Cheng J, Chen H. Predictive value of the combined cholesterol, high-density lipoprotein, glucose and frailty indices for cardiometabolic multimorbidity incidence: evidence from a national prospective cohort study. Cardiovasc Diabetol. 2026;25(1):200.","DOI":"10.1186\/s12933-026-03213-0"},{"issue":"1","key":"6356_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12944-025-02580-z","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, Bi L, Li Q, Wang Q, Lv T, Zhang P. Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys. Lipids Health Dis. 2025;24(1):155.","journal-title":"Lipids Health Dis"},{"key":"6356_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1100\/tsw.2001.58","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323\u201336.","journal-title":"ScientificWorldJournal"},{"key":"6356_CR24","doi-asserted-by":"publisher","first-page":"1499099","DOI":"10.3389\/fcvm.2024.1499099","volume":"11","author":"H Gao","year":"2024","unstructured":"Gao H, Ma Q, Li J, Zhang Q. Association of frailty with cardiovascular and all-cause mortality in community-dwelling older adults: insights from the Chinese longitudinal healthy longevity survey. Front Cardiovasc Med. 2024;11:1499099.","journal-title":"Front Cardiovasc Med"},{"key":"6356_CR25","doi-asserted-by":"crossref","unstructured":"Xu L, Ma J, Liu J, Li Y, Xu Y. The effects of a body shape index and remnant cholesterol inflammatory index on incident cardiovascular diseases: insights from a nationwide cohort study. Lipids Health Dis. 2026;25(1):87.","DOI":"10.1186\/s12944-026-02893-7"},{"issue":"38","key":"6356_CR26","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.3346\/jkms.2023.38.e295","volume":"38","author":"JH Heo","year":"2023","unstructured":"Heo JH, Jo SH. Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease. J Korean Med Sci. 2023;38(38):e295.","journal-title":"J Korean Med Sci"},{"key":"6356_CR27","doi-asserted-by":"publisher","first-page":"1576602","DOI":"10.3389\/fendo.2025.1576602","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Fu H, Xu H, Yang H, Min X, Wu W, et al. Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk. Front Endocrinol (Lausanne). 2025;16:1576602.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"6356_CR28","doi-asserted-by":"publisher","first-page":"114960","DOI":"10.4330\/wjc.v18.i2.114960","volume":"18","author":"SH Tan","year":"2026","unstructured":"Tan SH, Wu JL, Zhuo SX, Zhang Y, Wang M. Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies. World J Cardiol. 2026;18(2):114960.","journal-title":"World J Cardiol"},{"key":"6356_CR29","doi-asserted-by":"crossref","unstructured":"Frak W, Wojtasinska A, Lisinska W, Mlynarska E, Franczyk B, Rysz J. Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines. 2022;10(8):1938.","DOI":"10.3390\/biomedicines10081938"},{"issue":"4","key":"6356_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s00125-006-0522-y","volume":"50","author":"C D\u2019Alessandris","year":"2007","unstructured":"D\u2019Alessandris C, Lauro R, Presta I, Sesti G. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. 2007;50(4):840\u20139.","journal-title":"Diabetologia"},{"issue":"3","key":"6356_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2337\/db12-0133","volume":"62","author":"K Tanigaki","year":"2013","unstructured":"Tanigaki K, Vongpatanasin W, Barrera JA, Atochin DN, Huang PL, Bonvini E, et al. C-reactive protein causes insulin resistance in mice through Fcgamma receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes. 2013;62(3):721\u201331.","journal-title":"Diabetes"},{"key":"6356_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/cells11142163","volume":"11","author":"T Speelman","year":"2022","unstructured":"Speelman T, Dale L, Louw A, Verhoog NJD. The association of acute phase proteins in stress and inflammation-induced T2D. Cells. 2022;11:14.","journal-title":"Cells"},{"issue":"1","key":"6356_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.RV22044","volume":"33","author":"M Katamine","year":"2026","unstructured":"Katamine M, Minami Y, Ako J. High-sensitivity C-reactive protein and residual inflammatory risk in coronary artery disease: the pathophysiology, prognosis, and emerging therapies. J Atheroscler Thromb. 2026;33(1):1-12.","journal-title":"J Atheroscler Thromb"},{"issue":"9","key":"6356_CR34","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","volume":"43","author":"EP Navarese","year":"2023","unstructured":"Navarese EP, Vine D, Proctor S, Grzelakowska K, Berti S, Kubica J, et al. Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a mendelian randomization study. Arterioscler Thromb Vasc Biol. 2023;43(9):e373\u201380.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"6356_CR35","doi-asserted-by":"publisher","first-page":"108360","DOI":"10.1016\/j.jdiacomp.2022.108360","volume":"37","author":"X Zheng","year":"2023","unstructured":"Zheng X, Jiang M, Ren X, Han L. The longitudinal association of remnant cholesterol with diabetes in middle-aged and elderly Chinese: a nationwide population-based cohort study. J Diabetes Complications. 2023;37(1):108360.","journal-title":"J Diabetes Complications"},{"key":"6356_CR36","doi-asserted-by":"crossref","unstructured":"Li Z, Zhong B, Xu W, Sun L, Hu X. Cumulative inflammatory index and the risk of cardiometabolic multimorbidity: a prospective cohort study among middle-aged and older adults in China. J Health Popul Nutr. 2026;45(1):121.","DOI":"10.1186\/s41043-026-01289-8"},{"key":"6356_CR37","unstructured":"Zhu J, Zhou D, Wang J, Yang Y, Chen D, He F, et al. Frailty and cardiometabolic diseases: a bidirectional Mendelian randomisation study. Age Ageing. 2022;51(11):afac256."},{"issue":"11","key":"6356_CR38","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/gerona\/glad125","volume":"78","author":"T Ma","year":"2023","unstructured":"Ma T, He L, Luo Y, Fu D, Huang J, Zhang G, et al. Frailty, an independent risk factor in progression trajectory of cardiometabolic multimorbidity: a prospective study of UK Biobank. J Gerontol Biol Sci Med Sci. 2023;78(11):2127\u201335.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"9","key":"6356_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505\u201322.","journal-title":"Nat Rev Cardiol"},{"key":"6356_CR40","doi-asserted-by":"publisher","first-page":"111302","DOI":"10.1016\/j.exger.2021.111302","volume":"148","author":"SM Barbalho","year":"2021","unstructured":"Barbalho SM, Tofano RJ, Chagas EFB, Detregiachi CRP, de Alvares Goulart R, Flato UAP. Benchside to the bedside of frailty and cardiovascular aging: main shared cellular and molecular mechanisms. Exp Gerontol. 2021;148:111302.","journal-title":"Exp Gerontol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06356-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:03:23Z","timestamp":1792587803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06356-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6356"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06356-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The conduct of the CHARLS project strictly conformed to the ethical guidelines established by the Declaration of Helsinki. Ethical approval for this study was obtained from the Institutional Review Board of Peking University (IRB00001052-11015).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"949"}}